Neuphoria Therapeutics Inc.
USD3.34
+0.04 (+1.21%)
CEO
Spyridon Papapetropoulos
IPO Date
2021-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.38
Prev. Close
$3.30
Day Low
$3.34
Day High
$3.41
52W Low
$3.19
52W High
$21.40
Market Cap
$0.02B
Volume
0.05M
| -53.5 |
| 30 Jun 2023 | FY | 0.0% | 0.0% | -219.7% | -165.9% | 0.02 | 4.87 | -150.7 |
| 30 Jun 2022 | FY | 100.0% | -8253.7% | -55.6% | -48.4% | 0.01 | 12.46 | -433.3 |
| 30 Jun 2021 | FY | 0.0% | 0.0% | -18.3% | -16.0% | 0.02 | 13.10 | -2343.5 |
| 30 Jun 2020 | FY | 100.0% | -15255.2% | -56.1% | -20.7% | 0.96 | 1.01 | -2376.8 |
| 30 Jun 2019 | FY | 100.0% | -252.8% | -54.6% | -18.0% | 0.97 | 1.82 | -1627.6 |
| 30 Jun 2018 | FY | 100.0% | -668.3% | -147.9% | -38.6% | 1.27 | 2.70 | -520.5 |
| 30 Jun 2017 | FY | 100.0% | -125.6% | -16.7% | -8.0% | 0.46 | 3.92 | -1775.2 |
| 30 Jun 2016 | FY | 100.0% | -237.8% | -39.1% | -18.9% | 0.53 | 5.10 | -729.5 |
| 1.6 |
| 30 Sept 2025 | Q1 | 0.0% | 0.0% | -119.8% | -54.8% | 0.01 | 2.72 | -0.4 |
| 30 Jun 2025 | Q4 | 100.0% | 141.8% | -51.4% | -34.2% | 0.01 | 3.56 | -0.2 |
| 31 Mar 2025 | Q3 | 100.0% | 75.1% | 72.3% | 61.2% | 0.01 | 11.01 | 17.9 |
| 31 Dec 2024 | Q2 | 100.0% | -293.2% | -22.8% | -17.3% | 0.01 | 2.06 | -63.9 |
| 30 Sept 2024 | Q1 | 0.0% | 0.0% | -6.9% | -5.2% | 0.01 | 3.30 | -260.1 |
| 30 Jun 2024 | Q4 | 0.0% | 0.0% | -23.0% | -14.5% | 0.02 | 3.45 | -47.3 |
| 31 Mar 2024 | Q3 | 0.0% | 0.0% | -21.7% | 0.0% | 0.00 | 0.00 | -100.6 |
| 31 Dec 2023 | Q2 | 0.0% | 0.0% | -33.7% | -25.2% | 0.05 | 3.81 | -83.4 |